FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994539763> ?p ?o ?g. }

• W1994539763 endingPage "39" @default.
• W1994539763 startingPage "33" @default.
• W1994539763 abstract "There is no published overview of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) failure modes in advanced non-small-cell lung cancer (NSCLC). This study aimed to classify the diversity of EGFR-TKI failure, and to investigate the usefulness of clinical modes in subsequent management and prognosis.One-hundred and twenty consecutive clinical trial patients with EGFR-TKI failure were enrolled as the training set to establish a clinical model based on clinical factors. Another 107 routine patients were enrolled as the validating set according to a Bayes discriminant analysis. EGFR mutations and c-MET amplification were analyzed. Kaplan-Meier survival analysis was used to test the differences among three clinical modes and subsequent management.The duration of disease control, evolution of tumor burden, and clinical symptom were verified as feasible grouping variables. A correct grouping rate achieved 87.9%. The cohort was classified into three groups, as follows: 130 patients with dramatic progression, 42 with gradual progression, and 55 with local progression. Progression-free survivals (PFSs) for the dramatic progression, gradual progression, and local progression groups were 9.3, 12.9, and 9.2 months, respectively (P = 0.007). Overall survivals for the groups (OSs) were 17.1, 39.4, and 23.1 months, respectively (P < 0.001). TKI continuation was superior to switching chemotherapy in a subsequent setting for gradual progression (39.4 months vs. 17.8 months; P = 0.02). The difference of EGFR or c-MET among the three groups was not significant.Clinical modes of EGFR-TKI failure could favor strategies for subsequent treatment and predicting a survival benefit in advanced NSCLC." @default.
• W1994539763 created "2016-06-24" @default.
• W1994539763 creator A5004598929 @default.
• W1994539763 creator A5009003205 @default.
• W1994539763 creator A5034124730 @default.
• W1994539763 creator A5038306289 @default.
• W1994539763 creator A5043568223 @default.
• W1994539763 creator A5043928765 @default.
• W1994539763 creator A5046162972 @default.
• W1994539763 creator A5056312424 @default.
• W1994539763 creator A5056694430 @default.
• W1994539763 creator A5056759536 @default.
• W1994539763 creator A5061992274 @default.
• W1994539763 creator A5072012669 @default.
• W1994539763 creator A5072813027 @default.
• W1994539763 creator A5074151953 @default.
• W1994539763 creator A5075426616 @default.
• W1994539763 creator A5082411167 @default.
• W1994539763 creator A5089732639 @default.
• W1994539763 date "2013-01-01" @default.
• W1994539763 modified "2023-09-28" @default.
• W1994539763 title "Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer" @default.
• W1994539763 cites W1974918522 @default.
• W1994539763 cites W1979536922 @default.
• W1994539763 cites W1984269605 @default.
• W1994539763 cites W1998971866 @default.
• W1994539763 cites W2002937040 @default.
• W1994539763 cites W2006262863 @default.
• W1994539763 cites W2020242834 @default.
• W1994539763 cites W2020888019 @default.
• W1994539763 cites W2043696829 @default.
• W1994539763 cites W2047665602 @default.
• W1994539763 cites W2052378862 @default.
• W1994539763 cites W2054930937 @default.
• W1994539763 cites W2068244265 @default.
• W1994539763 cites W2073343603 @default.
• W1994539763 cites W2093613683 @default.
• W1994539763 cites W2095191469 @default.
• W1994539763 cites W2095618958 @default.
• W1994539763 cites W2109567704 @default.
• W1994539763 cites W2111662961 @default.
• W1994539763 cites W2112602910 @default.
• W1994539763 cites W2115425452 @default.
• W1994539763 cites W2118320591 @default.
• W1994539763 cites W2119831956 @default.
• W1994539763 cites W2122553809 @default.
• W1994539763 cites W2128208856 @default.
• W1994539763 cites W2129360604 @default.
• W1994539763 cites W2132157071 @default.
• W1994539763 cites W2134630203 @default.
• W1994539763 cites W2134897113 @default.
• W1994539763 cites W2138089710 @default.
• W1994539763 cites W2139248078 @default.
• W1994539763 cites W2142865455 @default.
• W1994539763 cites W2154662831 @default.
• W1994539763 cites W2158280531 @default.
• W1994539763 cites W2160500377 @default.
• W1994539763 cites W2160982674 @default.
• W1994539763 cites W2166084034 @default.
• W1994539763 cites W2166351918 @default.
• W1994539763 cites W2171138576 @default.
• W1994539763 cites W3108750466 @default.
• W1994539763 doi "https://doi.org/10.1016/j.lungcan.2012.09.016" @default.
• W1994539763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23079155" @default.
• W1994539763 hasPublicationYear "2013" @default.
• W1994539763 type Work @default.
• W1994539763 sameAs 1994539763 @default.
• W1994539763 citedByCount "137" @default.
• W1994539763 countsByYear W19945397632013 @default.
• W1994539763 countsByYear W19945397632014 @default.
• W1994539763 countsByYear W19945397632015 @default.
• W1994539763 countsByYear W19945397632016 @default.
• W1994539763 countsByYear W19945397632017 @default.
• W1994539763 countsByYear W19945397632018 @default.
• W1994539763 countsByYear W19945397632019 @default.
• W1994539763 countsByYear W19945397632020 @default.
• W1994539763 countsByYear W19945397632021 @default.
• W1994539763 countsByYear W19945397632022 @default.
• W1994539763 countsByYear W19945397632023 @default.
• W1994539763 crossrefType "journal-article" @default.
• W1994539763 hasAuthorship W1994539763A5004598929 @default.
• W1994539763 hasAuthorship W1994539763A5009003205 @default.
• W1994539763 hasAuthorship W1994539763A5034124730 @default.
• W1994539763 hasAuthorship W1994539763A5038306289 @default.
• W1994539763 hasAuthorship W1994539763A5043568223 @default.
• W1994539763 hasAuthorship W1994539763A5043928765 @default.
• W1994539763 hasAuthorship W1994539763A5046162972 @default.
• W1994539763 hasAuthorship W1994539763A5056312424 @default.
• W1994539763 hasAuthorship W1994539763A5056694430 @default.
• W1994539763 hasAuthorship W1994539763A5056759536 @default.
• W1994539763 hasAuthorship W1994539763A5061992274 @default.
• W1994539763 hasAuthorship W1994539763A5072012669 @default.
• W1994539763 hasAuthorship W1994539763A5072813027 @default.
• W1994539763 hasAuthorship W1994539763A5074151953 @default.
• W1994539763 hasAuthorship W1994539763A5075426616 @default.
• W1994539763 hasAuthorship W1994539763A5082411167 @default.
• W1994539763 hasAuthorship W1994539763A5089732639 @default.
• W1994539763 hasConcept C121608353 @default.

• next